Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Lantheus Biosciences Ltd.
Age
21–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Study participants were individuals with DS and healthy volunteers (HVs).
* \>=21 and \<= 40 years of age
* Mini-Mental State Examination (MMSE) \>= 28
* Clinical Dementia Rating (CDR) of 0
* \>= 40 years of age
You may not be if
* Unstable medical or psychiatric condition, study specific screening procedures with the understanding that the patient has the right to withdraw from the study at any time
Clareo Health | Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.
